[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=a157349f2acfa9b27fd2a6524bb4cb41512f9c78400f727bf010edca32e17abb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749141360,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 135075348,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=a157349f2acfa9b27fd2a6524bb4cb41512f9c78400f727bf010edca32e17abb"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of \"The Centrifuge Sessions\"",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / June 5, 2025 / At Gilead, we're advancing new ways to help end the HIV epidemic by delivering innovative therapies to those who need them most. In our latest episode of The Centrifuge Sessions, Magdeleine Hung, ...",
    "url": "https://finnhub.io/api/news?id=87d6bd58688b7571991cd20fc319df6544fabc9ce67834c41c17a6ecc573cb8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749129600,
      "headline": "Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of \"The Centrifuge Sessions\"",
      "id": 135063880,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / June 5, 2025 / At Gilead, we're advancing new ways to help end the HIV epidemic by delivering innovative therapies to those who need them most. In our latest episode of The Centrifuge Sessions, Magdeleine Hung, ...",
      "url": "https://finnhub.io/api/news?id=87d6bd58688b7571991cd20fc319df6544fabc9ce67834c41c17a6ecc573cb8c"
    }
  },
  {
    "ts": null,
    "headline": "Harbor AlphaEdge Large Cap Value ETF Q1 2025 Commentary",
    "summary": "During Q1, the Harbor AlphaEdge Large Cap Value ETF returned 0.98% (NAV), slightly underperforming the Harbor AlphaEdge Large Cap Value Index.",
    "url": "https://finnhub.io/api/news?id=3afe42dd4a7b3e00e067a10e604112a5f51496fe1d5a7c56470ae8be71444339",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749121620,
      "headline": "Harbor AlphaEdge Large Cap Value ETF Q1 2025 Commentary",
      "id": 135046913,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2195832722/image_2195832722.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "During Q1, the Harbor AlphaEdge Large Cap Value ETF returned 0.98% (NAV), slightly underperforming the Harbor AlphaEdge Large Cap Value Index.",
      "url": "https://finnhub.io/api/news?id=3afe42dd4a7b3e00e067a10e604112a5f51496fe1d5a7c56470ae8be71444339"
    }
  },
  {
    "ts": null,
    "headline": "A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech",
    "summary": "After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.",
    "url": "https://finnhub.io/api/news?id=d23e0bd069e6d64d74fd7e63279d0c318f39a1b9b39099f6f738eebdac6c2963",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749115800,
      "headline": "A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech",
      "id": 135043628,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.",
      "url": "https://finnhub.io/api/news?id=d23e0bd069e6d64d74fd7e63279d0c318f39a1b9b39099f6f738eebdac6c2963"
    }
  }
]